Both hubristic and thick!
The Company has made it clear that a successful reading in March 2024 "will see the company announce a clinically significant and statistically meaningful improvement"
In other words, your interpretation of what 'futility' analysis implies does not apply here. You are implying that the Company management are liars. Its horses for courses but clearly you don't have sufficient grey matter to understand that.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.035(6.25%) |
Mkt cap ! $352.7M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 60.0¢ | 55.5¢ | $1.804M | 3.083M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 56500 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 152931 | 5 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |